COMP <GO>

DMRA vs AAPG // PIOTROSKI F-SCORE QUALITY

Damora Therapeutics Inc. (NASDAQ) VS. Ascentage Pharma Group International American Depository Shares (NASDAQ) • 15-METRIC TALLY: DMRA 2 — AAPG 0

■ METRIC PARITY

DMRA — Damora Therapeutics Inc. ROARABLE D- • RQD 35/100

LAST: $21.60 (+0.51%) • MKT CAP: $1.33B

DES <GO> FA <GO> 10-K RED <GO>

piotroski-score

2/9

AAPG — Ascentage Pharma Group International American Depository Shares ROARABLE D • RQD 45/100

LAST: $13.56 (-6.20%) • MKT CAP: $1.27B

DES <GO> FA <GO> 10-K RED <GO>

piotroski-score

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DMRA VS. AAPG) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	DMRA	AAPG	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	—	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-0.49%	—	—	TIE	/fcf-yield <GO>
Operating Margin	—	—	—	TIE	/operating-margins <GO>
Net Profit Margin	—	—	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	—	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality ACTIVE	2/9	—	—	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	50.3	37.1	+13.20	DMRA	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$1.33B	$1.27B	$67.9M	DMRA	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	DMRA REV	AAPG REV	DMRA GROSS %	AAPG GROSS %	DMRA FCF	AAPG FCF
FY 2025	$590.4M	—	—	—	-$6.7M	—
FY 2024	$62.3M	—	—	—	-$18.6M	—
FY 2023	$111.7M	—	—	—	-$36.9M	—

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

DMRA // BETA —

AAPG // BETA —